Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Asian Pac J Allergy Immunol ; 2001 Jun; 19(2): 79-83
Artículo en Inglés | IMSEAR | ID: sea-36632

RESUMEN

The objective of this study was to determine the relationship between asthma symptoms and the degree of airway obstruction as measured by the forced expiratory volume in one second (FEV1) and peak expiratory flow rate (PEFR) in a group of 64 asthmatic patients with clinically stable disease attending a university-based urban asthma clinic. Asthma symptoms did not correlate with the degree of airway obstruction as measured by prebronchodilator PEFR (total asthma symptom score vs PEFR: r = -0.214, p = 0.104, n = 59) and only correlated poorly with prebronchodilator FEV1 (total asthma symptom score vs FEV1: r = -0.256, p = 0.041, n = 64). These results lend support to the recommendation that airway obstruction should be measured objectively when assessing patients with chronic persistent asthma.


Asunto(s)
Administración por Inhalación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Obstrucción de las Vías Aéreas/complicaciones , Asma/complicaciones , Broncodilatadores/uso terapéutico , Femenino , Volumen Espiratorio Forzado/efectos de los fármacos , Humanos , Malasia/epidemiología , Masculino , Persona de Mediana Edad , Ápice del Flujo Espiratorio/efectos de los fármacos , Valor Predictivo de las Pruebas , Encuestas y Cuestionarios , Índice de Severidad de la Enfermedad , Espirometría
2.
Asian Pac J Allergy Immunol ; 2000 Sep; 18(3): 135-40
Artículo en Inglés | IMSEAR | ID: sea-36465

RESUMEN

This study aimed to evaluate dry powder inhaler naive asthmatic patients' perception and preference of the Accuhaler, a multidose dry powder inhaler and the pressurized metered dose inhaler (pMDI). After the first instruction, 66.7% of 48 patients enrolled in the study could demonstrate the correct use of the Accuhaler. When the patients were asked to compare the pMDI and the Accuhaler after using the Accuhaler to administer salmeterol for 4 weeks, the Accuhaler scored significantly better than the pMDI for the following features: knowing how many doses are left, presence of an attached cover, taste, instruction for use, attractiveness, ease of use, ease of holding, shape, and comfortable mouthpiece. The pMDI scored better to the Accuhaler in terms of size. More patients preferred the Accuhaler than the pMDI; the presence of a dose counter and perceived ease of use were the main reasons cited for their preference for the Accuhaler.


Asunto(s)
Administración por Inhalación , Adolescente , Adulto , Aerosoles , Anciano , Albuterol/administración & dosificación , Antiasmáticos/administración & dosificación , Asma/tratamiento farmacológico , Broncodilatadores/administración & dosificación , Niño , Diseño de Equipo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nebulizadores y Vaporizadores , Satisfacción del Paciente , Polvos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA